Status:
COMPLETED
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
Lead Sponsor:
Allergy and Asthma Consultants, Wichita, Kansas
Collaborating Sponsors:
Aidan Foundation
Neil H. Riordan PhD
Conditions:
Duchenne's Muscular Dystrophy
Eligibility:
MALE
28-31 years
Phase:
PHASE1
Brief Summary
This research study is designed to evaluate the effects of human umbilical cord mesenchymal stem cells (UC-MSCs), on Duchenne's muscular dystrophy (DMD). The potential muscle regenerative and anti-inf...
Eligibility Criteria
Inclusion
- Duchenne's Muscular Dystrophy
Exclusion
- None
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2017
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT02235844
Start Date
September 1 2014
End Date
September 30 2017
Last Update
September 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asthma and Allergy Consultants
Wichita, Kansas, United States, 67205